POM-V Prescription Required

Ecoporc Shiga Suspension for Injection for Pigs

Active ingredient: Genetically modified recombinant Stx2e antigen

Form

Injection

Species

Pigs

Manufacturer

Ceva Animal Health Ltd

VMD MA No.

15052/5006

What it's used for

Onset of immunity: 3 weeks21 days after vaccination Duration of immunity: 15 weeks after vaccination

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Genetically modified recombi...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Ecoporc Shiga Suspension for Injection for Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: 3 weeks21 days after vaccination
Duration of immunity: 15 weeks after vaccination

ear. It is recommended to use a needle appropriate for the age of the piglets
(preferred size 21G length 16 mm).
Prior to administration, shake the vaccine carefully.
A single intramuscular injection (1 ml) to pigs from the age of 4 days.

Do not use in cases of hypersensitivity to the active substance, to the adjuvant or to
any of the excipients.

Common
(1 to 10 animals / 100 animals
treated):
Injection site swelling
Hyperthermia
Uncommon
(1 to 10 animals / 1,000 animals
treated):
Behavioural disorders
1
Small local reaction (maximum of 5 mm), subsiding within a short time (up to seven
days) without treatment.
A slight rise in body temperature (maximum of 1.7 °C), subsiding within a short time
(maximum of two days) without treatment.
Temporary mild behavioural disturbances.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See also the last section of the package leaflet for
respective contact details.

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental self-injection seek medical advice immediately and show the
package leaflet or the label to the physician.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.

Store in a refrigerator (2 °C – 8 °C).
Do not freeze.
Protect from light.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.